GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and Electroencephalography.
Iranian journal of child neurology. · 01.01.2024 · 18 (2) · 127-140
DOI: 10.22037/ijcn.v18i2.40751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian journal of child neurology., erschienen am 01.01.2024. Verfasst von Parvaneh Karimzadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Gangliosidosis is one of the hereditary metabolic diseases caused by the accumulation of Gangliosid in the central nervous system, leading to severe and progressive neurological deficits. Regarding phenotype, GM1 and GM2-Gangliosidosis are divided into Infantile, Juvenile, and Adult. Materials & Methods: In this study, thirty-seven patients with GM1 and GM2-Gangliosidosis were referred to the neurology department of Mofid Children's Hospital in Tehran, Iran, whose disease was confirmed from September 2019 to December 2021. This study assessed age, sex, and developmental status before the onset of the disease, clinical manifestations, brain imaging, and electroencephalography.
Results
97.20% of patients were the result of family marriage. Approximately 80% of juvenile patients were developmentally normal before the onset of the disease. Developmental delay was more common among infantile GM1-Gangliosidosis than infantile GM2-Gangliosidosis, but in total, more than 50% of GM1&GM2-Gangliosidosis patients had reached their developmental milestone before the onset of the disease. With the onset of disease symptoms, 100% of patients regressed in terms of movement, 97.20% of them mentally, and 75% of them had seizures during the disease. The most common clinical findings were cherry-red spot, Mongolian spot, macrocephaly, organomegaly, hyperacusis, and scoliosis. The most common brain imaging findings included bilateral thalamus involvement, brain atrophy, PVL, and delayed myelination. The most common finding in electroencephalography was background low voltage with abnormal sharp waves.
Conclusion
This study concluded that most of the patients are the result of family marriage, and most of the juvenile patients are developmentally normal before the onset of the disease. In addition, more than 50% of infantile patients reach their developmental milestones before the onset of the disease. The most common clinical findings of these patients are seizures, cherry-red spot, macrocephaly, hyperacusis, Mongolian spot, and bilateral involvement of the thalamus.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Pediatric Neurology Department, Mofid Children's Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Epidemiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Pediatrics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Karimzadeh, P., Ebrahimi, M., Etemad, K., Ahmad Abadi, F., & Hosseini Nezhad, Z. (2024). GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and Electroencephalography. Iranian journal of child neurology., 18(2), 127-140. https://doi.org/10.22037/ijcn.v18i2.40751
Vancouver
Karimzadeh P, Ebrahimi M, Etemad K, Ahmad Abadi F, Hosseini Nezhad Z. GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and Electroencephalography. Iranian journal of child neurology.. 2024;18(2):127-140. doi:10.22037/ijcn.v18i2.40751
BibTeX
@article{Karimzadeh2024,
author = {Karimzadeh, Parvaneh and Ebrahimi, Masomeh and Etemad, Korosh and Ahmad Abadi, Farzad and Hosseini Nezhad, Zahra},
title = {GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and Electroencephalography},
journal = {Iranian journal of child neurology.},
year = {2024},
volume = {18},
number = {2},
pages = {127--140},
doi = {10.22037/ijcn.v18i2.40751}
}
EUVIMED